These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22382005)

  • 1. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response.
    Naruse K; Sado T; Noguchi T; Tsunemi T; Yoshida S; Akasaka J; Koike N; Oi H; Kobayashi H
    J Reprod Immunol; 2012 Mar; 93(2):69-74. PubMed ID: 22382005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis.
    Moser B; Bekos C; Zimprich F; Nickl S; Klepetko W; Ankersmit J
    Biochem Biophys Res Commun; 2012 Mar; 420(1):96-101. PubMed ID: 22405771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
    Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
    Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
    Myles A; Viswanath V; Singh YP; Aggarwal A
    J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.
    Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V
    Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus.
    Skrha J; Kalousová M; Svarcová J; Muravská A; Kvasnička J; Landová L; Zima T; Skrha J
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):277-81. PubMed ID: 22549347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1-RAGE signaling pathway in severe preeclampsia.
    Zhu L; Zhang Z; Zhang L; Shi Y; Qi J; Chang A; Gao J; Feng Y; Yang X
    Placenta; 2015 Oct; 36(10):1148-52. PubMed ID: 26303759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome.
    Ingels C; Derese I; Wouters PJ; Van den Berghe G; Vanhorebeek I
    Shock; 2015 Feb; 43(2):109-16. PubMed ID: 25394242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Receptor for Advanced Glycation Endproducts in Hypertensive Disorders of Pregnancy.
    Akasaka J; Naruse K; Sado T; Uchiyama T; Makino M; Yamauchi A; Ota H; Sakuramoto-Tsuchida S; Itaya-Hironaka A; Takasawa S; Kobayashi H
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia.
    Zhang H; Zhang Y; Yang F; Li L; Liu S; Xu Z; Wang J; Sun S
    Mol Biosyst; 2011 Aug; 7(8):2470-9. PubMed ID: 21677994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia.
    Cooke CL; Brockelsby JC; Baker PN; Davidge ST
    Hypertens Pregnancy; 2003; 22(2):173-84. PubMed ID: 12909002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of inflammation in preeclampsia.
    Fialová L; Kalousová M; Soukupová J; Malbohan I; Madar J; Frisová V; Stípek S; Zima T
    Prague Med Rep; 2004; 105(3):301-10. PubMed ID: 15782556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia.
    Wang B; Koga K; Osuga Y; Hirata T; Saito A; Yoshino O; Hirota Y; Harada M; Takemura Y; Fujii T; Taketani Y
    Am J Reprod Immunol; 2011 Aug; 66(2):143-8. PubMed ID: 21241404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of maternal serum hypoxia inducible factor-1α, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia.
    Alici Davutoğlu E; Akkaya Firat A; Ozel A; Yılmaz N; Uzun I; Temel Yuksel I; Madazlı R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(15):1976-1982. PubMed ID: 28574293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.